Eisai Co., Ltd.
EISAI CO LTD U/ADRwww.eisai.com
15
MENTIONS
5
EPISODES
5
PODCASTS
Search complete. 15 mentions across 5 episodes found for "Eisai Co., Ltd.".
Sep 14, 2026
speaker_0NARRATOR
The following presentation from Answers in CME is part of an educational activity titled "Optimizing Real-World Management of Early Alzheimer's Disease: Maintenance Therapy and Long-Term Evidence." To access the full program and supporting materials and to claim your certificate, please visit the activity URL in the episode description.
speaker_0NARRATOR
This activity is supported by an independent educational grant from Eisai.
speaker_0NARRATOR
This is a unique CME program.
speaker_0NARRATOR
We've conducted a survey with neurologists, nurse practitioners, and physician associates, including community clinicians and internal medicine specialists, to gather their feedback and questions about real-world treatment of early Alzheimer's disease with anti-amyloid therapies.
Maya PatelHOST
If they actually power the study for it, Roche is trying to change what quality weight loss means on a label, and that's a much bigger swing than the upfront implies.
Maya PatelHOST
On the regulatory side, today was the FDA's action date for Leqembi Iclic, Biogen and Eisai's once-weekly subcutaneous lecanemab, this time as the starting dose for early Alzheimer's.
Maya PatelHOST
This date only exists because the agency deemed additional submitted material a major amendment in the spring and pushed the review out.
Alex MercerHOST
Subcutaneous maintenance is already approved, though.
Chris GarabedianHOST
... at multiple universities.
Chris GarabedianHOST
When you were going through these degrees, and we're gonna get to Eisai in a minute, but what, what were you...
Chris GarabedianHOST
Were you thinking you wanted to be a professor? Did you think you would practice medicine? Did you know industry was something? 'Cause Japan had a long, great history of pharmaceuticals-
BT SlingsbyGUEST
Yeah
Chris GarabedianHOST
Yeah, yeah.
Chris GarabedianHOST
Well, and we're gonna get to that 'cause y- I mean, again, it's a very unique model.
Chris GarabedianHOST
So Eisai, how did that come about, that role? Um, y- you were there for a few years.
Chris GarabedianHOST
Uh-
JimmyHOST
This period also saw the rise of Zen Buddhism, which would become one of the most significant influences on the development of the Japanese tea ceremony.
JimmyHOST
The monk Eisai, who founded Japan's Rinzai Zen School, returned from study in Song China with tea seeds and the custom of preparing powdered tea.
JimmyHOST
In China's monasteries, tea was used in rituals and to sustain meditation.
JimmyHOST
and Eisai eagerly promoted tea in Japan as a means to health and spiritual benefit.
JimmyHOST
He planted tea bushes on temple lands and extolled the drink's virtues in his 1211 treatise Kisa Yojoki, generally translated as drinking tea for health.
JimmyHOST
Eisai even presented tea to Shogun Minamoto Sanetomo, reportedly curing the ruler's ailment and convincing the samurai elite of tea's merits.
JimmyHOST
Backed by the patronage of warriors and clergy, tea cultivation spread.
JimmyHOST
By the 14th century, it was grown widely beyond the old capitals.
Danielle GolovinPANELIST
So in the case of Iterion, they block a cofactor called TBL1 that normally protects nuclear beta-catenin from being degraded.
Danielle GolovinPANELIST
Now, Eisai and Prism's molecule blocks beta-catenin's interaction with a cofactor called CBP specifically.
Danielle GolovinPANELIST
This leaves its close relative P300 alone, and that biases the cell toward differentiation rather than proliferation.
Danielle GolovinPANELIST
And I would say DewPoint is probably the most different of the five.
Danielle GolovinPANELIST
And Sapiens also has strong Phase II combination data in colorectal cancer and is moving toward a bigger randomized Phase IIB.
Danielle GolovinPANELIST
Iterion is in Phase I/II.
Danielle GolovinPANELIST
Eisai and Prism are Phase I/II.
Danielle GolovinPANELIST
They both have some early data.